Clinical Study Provides Evidence for the Use of Arla Foods Ingredients’ Lacprodan® IF-3070 in Infant Formula

COPENHAGEN, Denmark, March 24 (Bernama-GLOBE NEWSWIRE) — A clinical study published in Nutrients has shown that infant formula containing Arla Foods Ingredients’ Lacprodan® IF-3070 was well tolerated in infants, with growth and development indicators remaining within an appropriate range.1 The findings provide scientific evidence for formula development in early life nutrition.

Lacprodan® IF-3070 is a partially hydrolysed whey protein ingredient specially designed to support gastrointestinal comfort in healthy infants.

https://mrem.bernama.com/viewsm.php?idm=53827